Author:
Bhawsar Satish,Joshi Sanjeev,Deshpande Prasad,Yeole Ravindra,Bhagwat Sachin,Patel Mahesh
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference23 articles.
1. Recent developments in β-lactamase and extended spectrum β-lactamase;Samaha-Kfoury;Br Med J,2003
2. Gram-positive resistance: challenge for the development of new antibiotics;Baquero;J Antimicrob Chemother Suppl A,1997
3. (a) Projan S. J, why is big pharma getting out of antibacterial drug discovery, Current Opinion in Microbiology, 6, 2003, 427-430. DOI: 10.1016/j.mib.2003.08.003.
4. (b) Projan S. J, Youngman P.J, New solutions badly needed, Current Opinion in Microbiology, 5, (2002), 463-465. DOI: 10.1016/s1369-5274(02)00364-8.
5. Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance;Hooper;Cold Spring Harb Perspect Med,2016